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Abstract
Rous sarcoma virus (RSV) requires incomplete splicing of its viral transcripts to maintain efficient replication. A splicing inhibitor
element, the negative regulator of splicing (NRS), is located near the 5 end of the RNA but the significance of this positioning is not known.
In a heterologous intron the NRS functions optimally when positioned close to the authentic 5 splice site. This observation led us to
investigate the basis of the position dependence. Four explanations were put forth and stressed the role of three major elements involved
in splicing, the 3 splice site, the 5 splice site, and the 5 end cap structure. NRS function was unrelated to its position relative to the 3
splice site or the cap structure and appeared to depend on its position relative to the authentic 5 splice site. We conclude that position
dependence may reflect distance constraints necessary for competition of the NRS with the authentic 5 splice site for pairing with the 3
splice sites.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The primary transcripts of retroviruses are subject to
RNA splicing control such that appropriate levels of sub-
genomic mRNAs are produced, but the majority (50%) of
the RNA remains unspliced. The unspliced RNA is ex-
ported to the cytoplasm where it serves as an mRNA for
Gag and Gag-Pol proteins or as the genome for progeny
virions (Coffin, 1996). In Rous sarcoma virus (RSV), splic-
ing regulation results from the action of several cis signals
within the viral RNA and components of the host splicing
machinery. These cis elements include a splicing enhancer
that promotes use of the env 3 splice site (ss) (Fu et al.,
1991), an element that represses use of the src 3 ss (Ber-
berich and Stoltzfus, 1991), weak 3 ss (Katz and Skalka,
1990; McNally and Beemon, 1992; Zhang and Stoltzfus,
1995), and a novel element called the negative regulator of
splicing, or NRS, that globally represses viral RNA splicing
(Arrigo and Beemon, 1988; Stoltzfus and Fogarty, 1989).
The NRS also plays a role in efficient polyadenylation of
viral RNAs (Fogel et al., 2002). The importance of these
elements for splicing regulation is highlighted by the fact
that deletions and mutations cause oversplicing and lead to
replication defects (Hibbert et al., 1999; Katz et al., 1988;
Zhang and Stoltzfus, 1995).
Splicing takes place in a large, dynamic machine termed
the spliceosome. Central to the process are five small nu-
clear ribonucleoproteins (snRNPs: U1, U2, U4, U5, and U6)
that assemble stepwise on precursor mRNA, assist in bring-
ing the splice sites together, and very likely catalyze the
splicing reaction itself (Burge et al., 1999; Valadkhan and
Manley, 2001; Villa et al., 2002). The NRS is distinct from
the viral splice sites yet binds components of the splicing
machinery, including SR proteins and U1, U2, and U11
snRNPs (Gontarek et al., 1993; McNally and McNally,
1996), and a role for the SR proteins and U1 snRNP in
splicing inhibition has been established (Hibbert et al.,
1999; McNally and McNally, 1996, 1999). Despite binding
splicing factors, splicing does not normally occur from the
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NRS. It has been shown that the SR proteins associate with
an upstream region of the NRS and promote U1 snRNP
binding to the 3 end of the element (McNally and McNally,
1999). The NRS can interact with a downstream heterolo-
gous 3 ss in a U1-dependent manner but splicing does not
occur (Cook and McNally, 1999). Recent data suggest that
U1 is released from the NRS and is replaced by U6 snRNP,
which occurs normally on an authentic 5 ss along the
splicing pathway, and that splicing inhibition likely results
from stalled splicing due to an inappropriate, non catalytic
U6 interaction (M.T. McNally, unpublished data). Thus, the
NRS can be viewed as a pseudo-5 ss that causes splicing
inhibition by sequestering the authentic 3 ss from its nor-
mal interaction with the authentic 5 ss.
The U1 binding site within the NRS resides 517 nt
downstream of the authentic viral 5 ss and over 4000 nts
from the env 3 ss. The position of the NRS near the 5 end
of the viral RNA may be critical for its activity. Interest-
ingly, the NRS shows position-dependent splicing inhibi-
tion in a heterologous myc intron (McNally et al., 1991).
Inhibitory activity was strongest when the NRS was posi-
tioned 167 nts into the intron, and activity was strong but
diminished when positioned 340 nts downstream of the
authentic 5 ss. Little inhibition was observed at positions
602 or 803 nts into the intron or in the downstream exon.
Splicing suppression was also observed at an exon position
136 nts upstream of the authentic 5 ss but no activity was
seen 435 nts upstream. These observations are consistent
with the NRS representing a pseudo-5 ss that competes
with the authentic 5 ss to encumber the authentic 3 ss and
suggest that its position relative to splicing signals is im-
portant for successful competition.
Since in vitro studies suggest that the 3 proximal of two
competing 5 splice sites is selected for 3 ss pairing if each
of the sites is strong (Eperon et al., 1993, 2000), one might
expect the NRS to function more efficiently when moved
further downstream from the authentic 5 ss, yet this is not
observed. The cap structure has been reported to facilitate
U1 snRNP binding to cap-proximal 5 ss but is not required
for U1 binding to internal sites (Lewis et al., 1996). Another
study concluded that the cap influences U6 snRNP binding
to productively used 5 splice sites (O’Mullane and Eperon,
1998). Based on these studies, it seemed possible that NRS
position dependence reflects a requirement of the NRS to be
within some critical distance of the cap structure to be
recognized (i.e., for U1/U6 snRNPs to bind), although ef-
fects of proximity to the authentic 5 or 3 splice sites are
also possible.
We sought to investigate the relationship between NRS
inhibition and NRS position relative to the 5 cap and the
authentic 5 ss and 3 ss to understand the basis for the
observed position dependence. Four possible models were
envisioned. First, the decreased inhibition efficiency ob-
served when the NRS is downstream in the intron may be
due to poor context or, in a second model, the NRS may not
function when close to the 3 ss. Third, the NRS might need
to be near the authentic 5 ss to be efficiently recognized as
a pseudo splice site. Last, because of the role of the cap
structure in recruiting U1 and/or U6 to cap-proximal 5
splice sites (Lewis et al., 1996; O’Mullane and Eperon,
1998), the NRS may need to be within a certain distance of
the 5 end cap to efficiently bind U1 and U6 snRNPs and
elicit inhibition. We tested these models by changing the
position of the NRS relative to the cap, 5 ss, and 3 ss and
found that the position of the NRS relative to the authentic
5 ss is of primary importance.
Results
Position-dependent splicing inhibition in 293 cells
Position-dependent NRS function was first observed in a
heterologous construct, pMyc23, which contains the
chicken myc gene (c-myc), including most of exon 2 (514
nt), all of intron 2 (971 nt), most of exon 3 (618 nt), and a
polyadenylation site from SV40. To facilitate development
of plasmids to investigate the basis of position-dependent
NRS function, a new series of plasmids based on pMyc23
was created which contained an NRS fragment (MroI-SphI)
with KpnI-XbaI sites flanking the ends inserted at various
sites in the myc intron (Fig. 1A). To show that the new NRS
constructs displayed position-dependence similar to the
original constructs, human 293 cells were transfected with
the constructs and RNase protection assays were performed
on total RNA to analyze NRS-mediated splicing inhibition.
As a control, an NRS mutant (mU1) that binds U1 less well
and displays impaired inhibition (McNally and McNally,
1999) was also inserted into the different intron sites.
As shown in Fig. 1B, RNA lacking an insert was efficiently
spliced (lane 1), whereas insertion of the NRS at the BstXI (B)
or SacII (S) sites decreased splicing from the myc 5 ss (lanes
2 and 3), which is indicative of splicing inhibition. In contrast
to the previous description of position dependence (McNally et
al., 1991), in 293 cells the NRS was not as effective at the B
site and was comparable to but less efficient than when previ-
ously placed at the S site. This may reflect a difference in cell
types, as chicken embryo fibroblasts (CEF) were originally
used. However, the NRS was still position dependent in that
splicing inhibition was not observed at the HindIII (H) or AflII
(A) sites (lanes 4 and 5). The decrease in myc 5 ss use was
attributed to NRS activity since inhibition was compromised
by a mutation (mU1) in the NRS U1 snRNP binding site that
was previously shown to diminish splicing inhibition (lanes
6–7). Thus, the new constructs demonstrated position-depen-
dent splicing inhibition in 293 cells.
Intron deletion rescues splicing inhibition at a
downstream site
The lack of splicing inhibition at the downstream intron
positions (H and A) may be due to a poor sequence context
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where the NRS is inserted, which hinders NRS recognition
and function. Since it is known that introns smaller than
70 nts are not spliced efficiently, it is also possible that the
NRS (a pseudo-5 ss) might not function when located too
close to the 3 ss. Another possibility is that the NRS may
need to be near the 5 end cap structure for proper recog-
nition, or it must be near the authentic 5 ss to effectively
compete for recognition. To distinguish between these pos-
sibilities, we made intron deletions in the construct where
the NRS was located at the inactive distal A site
(pMyc23(A)NRS). This maintained the context and dis-
tance between the NRS and 3 ss (168 nt) but brought the
NRS closer to the 5 ss and cap structure (Fig. 2A). Thus, if
poor context or proximity to the 3 ss is responsible for the
lack of activity at the A site, inhibition should remain poor
with the deletions.
Fig. 2B again shows position-dependent splicing inhibi-
tion (lanes 2–4) with no inhibition at the A site. With BH,
which brings the NRS to a position 368 nt downstream of
the 5 ss (slightly more distal than the relative position of
SacII site), no rescue of splicing inhibition was observed
(lane 5). However, with BK, which placed the NRS 167
nts from the 5 ss (the position of the BstXI site), some
inhibitory activity was restored (lane 6). The increase in
splicing inhibition was not due to elimination of some intron
sequence that was important for splicing since the deletions
Fig. 2. Intron deletion rescues NRS splicing inhibition at an inactive
downstream site. (A) Diagram (not to scale) of the Myc23(A)NRS con-
struct and indicated intron deletions (BH and BK). Distances between
the NRS at the AflII site and the 5 ss and 3 ss for the unaltered and
deletion constructs are indicated by brackets. (B) RNase protection assay as
in Fig. 1. B (BstXI), S (SacII), and A (AflII) indicate the WT NRS or mU1
intron insertion position; , no NRS insert. BH, a 435-bp BstXI-HindIII
deletion and BK, a 636-bp BstXI-KpnI deletion in the NRS-containing
constructs. BA, a 636-bp BstXI-AflII intron deletion in the pMyc23yw
parental vector. Probe is a lane containing undigested probe and mock is
protection of RNA from untransfected cells. Unsp and Sp, positions of
bands representing unspliced and spliced RNA. Below the lanes is the
quantitated percentage of unspliced RNA as determined by PhosphorIm-
ager analysis; the data are representative of two to four independent
experiments.
Fig. 1. Position-dependent splicing inhibition by the NRS. (A) Diagram
(not to scale) of the Myc23yw construct with myc exons as open boxes, the
intron as a line, and NRS insertion sites (B, BstXI; S, SacII; H, HindIII; and
A, AflII) indicated. The distances of the B, S, H, A insertion sites and 3
splice site from the authentic 5 ss and the 5 end cap is shown. A
schematic of the RNase protection probe used to measure unspliced and
spliced RNA levels, and the sizes of the probe and protected products, is
shown above. (B) RNase protection assay on RNA from transfected 293
cells. Total RNA from 293 cells transfected with the indicated constructs
was used for RNase protection with the 5 ss probe, and protected frag-
ments were run in a 6% denaturing polyacrylamide gel and visualized by
autoradiography. Myc23yw, the parental vector, NRS and mU1, the wild-
type NRS and the mU1 mutant, and mock is a protection of RNA from
untransfected cells. Unsp and Sp, positions of the unspliced and spliced
protected fragments. Below the lanes is the percentage of unspliced RNA
as determined by PhosphorImager analysis; the data are representative of at
least two separate experiments.
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in the absence of the NRS had no effect on splicing (lanes
10 and 11). Also, the inhibitory activity that was restored by
the BK deletion was due to NRS activity since it was
sensitive to the mU1 mutation (lane 9). The fact that inhi-
bition was not completely restored in BK may indicate
that close positioning of the NRS to the 3 ss is suboptimal
or that additional factors besides 5 ss proximity influence
NRS activity. These results indicate that the A site is com-
petent for NRS function and that elements important for
position dependence lie primarily in the upstream regions of
the heterologous construct. This led us to investigate the
possible roles of the 5 end cap structure and the authentic
5 ss in position dependence.
The mRNA 5 end cap does not contribute to NRS
position dependence
It is known that the cap structure plays an important role
in splicing in vitro (Edery and Sonenberg, 1985; Konarska
et al., 1984) and in vivo (Inoue et al., 1989) and that the cap
and the cap-binding complex (CBC) help define the cap-
proximal 5 ss by promoting binding of U1 snRNP (Lewis
et al., 1996) and recognition of the 5 ss by U6 snRNP
(Hwang and Cohen, 1996). Therefore, it is possible that the
cap structure and its binding proteins influence U1 binding
to the NRS, and position dependence would be explained if
this process functions over a finite distance. To explore this
possibility, the NRS was positioned at the inactive H intron
site and exon deletions were made that would maintain the
distance between the NRS and the 5 ss (602 nt) but de-
crease the distance to the cap from 1157 to 963 nt (PA) or
813 nt (PE) (Fig. 3A). Because the NRS functions at the S
site (895 nts from the cap), the PA deletion (NRS 813 nt
from cap) would be predicted to activate splicing inhibition
if cap distance is important. As seen in Fig. 3B, the largest
deletion itself had no effect on myc splicing (lane 9), the
NRS was inactive at the H site as expected (lane 4), and no
activation was seen with either deletion in the wild-type
(lanes 5 and 7) or mU1 (lanes 6 and 8) backgrounds. The
protected RNAs are smaller for the PE deletion since exon
sequences that hybridize to the probe were deleted (lanes
7–9). Thus, decreasing the distance between the cap and the
NRS at the inactive H site did not activate splicing inhibi-
tion.
As a further test of an influence of the cap on position
dependence, the NRS was placed at the functional B site and
the upstream exon was expanded such that the distance
between the NRS and the 5 ss was maintained (167 nt) but
the distance to the cap was increased from 722 to 900 nt
(small insert, S) or 1190 nt (large insert, L) (roughly equiv-
alent to the S and H positions, Fig. 1A). A loss of inhibition
with the latter construct would be expected if the cap is
involved in position dependence. Interestingly, this was the
opposite of what was observed (Fig. 4B). The amount of
unspliced myc RNA nearly doubled when the sense orien-
tations of the short and long stuffer fragments were inserted
into exon 2 (compare lanes 3 and 4 to lane 2). Inhibition was
even greater with the antisense long insert (lane 5). Again,
the increase in unspliced RNA was attributed to NRS ac-
tivity since the insertions had no effect on splicing of RNAs
lacking the NRS (lanes 10–12) and the increased inhibition
was sensitive to the mU1 mutation (lanes 6–9). Therefore,
in contrast to the results in Fig. 3, it appeared from these
data that there is an inverse relationship between NRS
activity and proximity to the cap. However, it is possible
that the effect was due to a cap influence on the authentic 5
ss rather than the NRS (see Discussion).
NRS splicing inhibition in a downstream intron
The cap structure and CBC selectively promote splicing
of the cap-proximal intron in two-intron constructs in vitro
(Lewis et al., 1996; Ohno et al., 1987). In model substrates
containing competing 5 splice sites (similar to inhibition by
the NRS), use of each site was increased by the cap
(O’Mullane and Eperon, 1998). If the cap is required for
position dependence by promoting U1 binding to the NRS,
then position dependence (and inhibition) should be lost
when the NRS is placed in a downstream intron. To explore
this possibility, two-intron constructs were made in which
the NRS was placed in the active B or inactive H sites in
Myc23yw, and an identical intron embedded within the
neomycin gene was placed upstream (Fig. 5A).
RNA from transfected 293 cells was subjected to RNase
protection with probes that distinguish splicing of the up-
stream and downstream introns. Because the two probes
have the intron sequence and 30 nts of exon sequence in
common, some protection of cross-hybridized probes was
expected. As shown in Fig. 5C, the downstream probe was
specific for the downstream myc23 intron (no full-size
bands in lane 1) and in the absence of the NRS the second
intron was spliced with an efficiency similar to that ob-
served with the single myc intron RNA (compare lanes 3
and 2). Variable levels of a band consistent with cross-
hybridization to upstream unspliced RNA were observed in
constructs with two introns (lanes 3–7) and with a construct
harboring the upstream intron only (lane 1). Importantly,
insertion of the NRS into the proximal B site in the down-
stream intron caused a decrease in splicing (lane 4), indi-
cating that the NRS is functional in the downstream intron,
and NRS activity remained position dependent in that no
inhibition was observed when the NRS was inserted in the
downstream H site (lane 5). Again, the observed decrease in
splicing was attributed to NRS inhibition since it was sen-
sitive to the mU1 mutation (lanes 6 and 7). These results
argue against a requirement for the cap in NRS function and
position dependence and favor the interpretation that prox-
imity to the 5 ss is important for NRS function.
It was shown previously that when placed in the up-
stream myc intron of pRSVNeo-int, which also has the
SV40 small t intron downstream, the NRS blocks splicing of
the myc intron but that the small t intron is unaffected
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(McNally et al., 1991). However, using the two-intron con-
struct here with the NRS in the downstream intron, some
inhibition of splicing of the upstream intron by the NRS was
observed. As shown in Fig. 5B, the upstream probe was
specific for the upstream intron (no signal in lane 2, the
195-nt cross-hybridizing band was run off the gel) and
Fig. 3. Decreasing the distance between the cap and the NRS at an inactive site does not rescue splicing inhibition. (A) Diagram (not to scale) of the
Myc23(H)NRS and PA and PE deletion constructs. PvuII (P), ApaI (Ap), and EspI (E) sites are shown. PA is a 194-nt PvuII-ApaI deletion and PE
is a 344-nt PvuII-EspI deletion. Distances between the 5 ss and cap and the NRS at the HindIII site are indicated by brackets. (B) RNase protection assay
as in Fig. 1. B, S, and H specify NRS wild-type (WT) or mU1 insert positions, and constructs with the deletions are indicated. Probe is a lane containing
undigested probe and mock is protection of RNA from untransfected cells. Unsp and Sp, positions of bands representing unspliced and spliced RNA.
Unsp(PE) and Sp(PE), positions of bands representing unspliced and spliced RNA from PE constructs; removal of exon sequences decreases the sizes
of the protected fragments. Below the lanes is the quantitated percentage of unspliced RNA as determined by PhosphorImager analysis; the data are
representative of two to four independent experiments.
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splicing of the upstream intron was as efficient in the ab-
sence of the NRS as splicing of a single intron Neo con-
struct (lanes 1 and 3). Surprisingly, splicing of the upstream
intron decreased when the NRS was present in the down-
stream B site (but not the H site) and the effect was sensitive
to the mU1 mutation. While the mechanism for this effect is
not known, it likely occurs through exon definition interac-
tions from the NRS across the second exon.
Discussion
There is considerable support for a model of NRS splic-
ing inhibition in which the NRS represents a U1-type
pseudo-5 ss that can be paired with and sequester a 3 ss in
a noncatalytic splicing complex (Cook and McNally, 1998,
1999; Hibbert et al., 1999; McNally and McNally, 1999;
Paca et al., 2001). Inhibition is predicated on the NRS
successfully competing with the authentic 5 ss for pairing
with the 3 ss and with one exception the NRS must be
downstream of the natural 5 ss to inhibit (McNally et al.,
1991). In vitro and in vivo studies indicate that the 3
ss-proximal of two competing 5 splice sites is chosen when
the competing 5 splice sites are both strong but that the
position of the competing sites is also a factor (Caceres et
al., 1994; Eperon et al., 1993, 2000). When inserted into the
myc intron B site where the NRS elicits inhibition, a 5 ss
from HIV effectively competes with the myc 5ss and is
Fig. 4. Increasing the distance between the cap and NRS does not eliminate splicing inhibition. (A) Diagram (not to scale) of the Myc23(B)NRS construct and small
(S, 178 nt) and large (L, 468 bp) exon insertions. Distances between the NRS at the BstXI site and the 5 ss and cap are indicated by brackets. (B) RNase protection
assay as in Fig. 1. (B) indicates NRS or mU1 insertion at the BstXI site; , no NRS insert. Indicated below are no exon insert (), the small fragment inserted in
the sense orientation (S), or the large fragment inserted in each orientation (L, L). Probe is a lane containing undigested probe and mock is protection of RNA
from untransfected cells. Unsp and Sp, positions of bands representing unspliced and spliced RNA. Below the lanes is the quantitated percentage of unspliced RNA
as determined by PhosphorImager analysis; the data are representative of two to four independent experiments.
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used efficiently (O’Reilly et al., 1995). It is difficult to
assess the strength of the NRS pseudo-5 ss but the presence
of a strong splicing enhancer element nearby (McNally and
McNally, 1996, 1998), the ability of the NRS to compete
with an authentic distal splice site to achieve inhibition, and
conversion of the NRS to a functional splice site by subtle
mutations that do not affect U1 base pairing (M.T. McNally,
unpublished data) suggest that the NRS can be recognized
efficiently by the splicing machinery. As the 3 proximal of
two competing 5 splice sites in our system, one might
expect the NRS to function better when closer to the 3 ss.
However, the opposite is observed here and in a previous
study (McNally et al., 1991).
Position dependence is not a trivial consequence of poor
context in the 3 portion of the heterologous intron since
repositioning the NRS from an inactive downstream site to
a site closer to the 5 end of the intron restored some NRS
splicing inhibition. This result also ruled out models in
which NRS activity is sensitive to close proximity to a 3 ss.
Restoration of splicing inhibition to the inactive site could
also be attributed to NRS activity rather than a nonspecific
consequence of intron manipulation since inhibition was
sensitive to a mutation known to inactivate the NRS. It thus
appeared that proximity to the authentic 5 ss or cap struc-
ture was important for NRS activity.
An attractive possibility was that the cap structure and
associated proteins influence recognition of the NRS and
that the beneficial effect of the cap has a defined distance
constraint; the NRS would fail to be recognized when po-
sitioned beyond this distance. Proposed roles of the cap in
promoting binding of U1 snRNP to 5 splice sites (Lewis et
al., 1996) or in facilitating replacement of U1 by U6 at the
Fig. 5. Position dependence in a downstream intron. (A) Diagram (not to scale) of the two intron construct, pNeo-Myc23. Open boxes are myc exon
sequences; lines are the myc intron; hatched boxes are Neo sequences; and the stippled box is from SV40. Shown above are depictions of the upstream and
downstream probes and the protected species. Diagrammed below the construct are potential cross-hybridizing products. The BstXI (B) and HindIII (H) sites
in the downstream intron where the NRS (shaded box) was inserted are indicated. (B and C) Results with the upstream probe and downstream probes,
respectively; RNase protection as in Fig. 1. pRSVNeo-int contains a single myc intron embedded in Neo sequences. Indicated are no insert into the
pNeo-Myc23 () or the NRS or mU1 mutant at the B or H sites. Probe is a lane containing undigested probe and mock is protection of RNA from
untransfected cells. The positions of the unspliced and spliced species is shown beside each autoradiogram. *, an unknown band detected by the Nmyc5ss
probe in two-intron construct but not in single-intron pNeo-int construct. Below the lanes is the quantitated percentage of unspliced RNA as determined by
PhosphorImager analysis; the data are representative of at least two independent experiments.
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5 ss (O’Mullane and Eperon, 1998) are relevant since U1
and U6 have been shown to be important for NRS splicing
inhibition (Hibbert et al., 1999; M.T. McNally, unpublished
data). Three observations argue against a role for the cap.
First, repositioning the cap to within an “acceptable” dis-
tance of an inactive downstream site did not activate the
NRS. Second, increasing the distance between an active site
and the cap to an “unacceptable” distance did not suppress
NRS splicing inhibition. Third, the NRS was functional and
showed position dependence in a downstream intron, which
is inconsistent with a requirement of the cap for inhibition.
One possibility is that the strong SR protein binding sites
within the NRS renders recognition of the NRS pseudo-5 ss
cap-independent. Interestingly, it may be that the cap influ-
ence on cap-proximal 5 ss choice operates over a finite
distance. Our observation that expanding the first exon
increased NRS inhibition could be interpreted to mean that
the authentic 5 ss was less efficiently recognized as the
distance from the cap was increased, which resulted in more
efficient NRS activity. This system can be exploited to
further test this idea.
It was previously shown that, when placed in the up-
stream myc intron of pRSVNeo-int, the NRS had no effect
on splicing of the downstream SV40 small t intron (Mc-
Nally et al., 1991). However, this was not true of the reverse
situation in the new two-intron construct used here; splicing
of the upstream intron decreased when the NRS was placed
in an active site in the downstream intron (although to a
lesser extent) and the effect again required the NRS U1 site.
Normally, the 5 and 3 splice sites flanking an internal exon
are identified by cross-exon interactions between U1 snRNP
and U2AF in fulfillment of the exon definition model (Ber-
get, 1995; Robberson et al., 1990; Wang et al., 1995). With
the NRS inserted into the downstream intron, it is possible
that aberrant exon definition interactions are established
between the upstream 3 ss of the second exon and the U1
snRNP bound to the downstream NRS pseudo-5 ss, which
might result in sequestration of the splice sites flanking the
exon and explain inhibition of both introns. Exon definition
interactions involving the NRS would not be predicted with
the NRS in the upstream intron, which may explain why
there was no effect on splicing of the downstream SV40
intron in the earlier report (McNally et al., 1991).
The combined results here rule out a direct role for the
cap and suggest that it is proximity to the authentic 5 ss that
determines NRS position dependence. Why might this be?
A mechanistic explanation for this has been elusive, but we
favor a kinetic model in which the authentic 5 ss and the
NRS are recognized cotranscriptionally and compete for
pairing with the 3 ss after it emerges from RNA polymer-
ase II (pol II). Position dependence in the heterologous
intron would be explained if, when the NRS is near the 5
ss, the NRS emerges from pol II soon after the 5 ss and
each are recognized and compete for the 3 ss as it emerges
from pol II. Likewise, when the NRS is farther downstream
in the intron, emergence of the NRS from pol II is soon
followed by the 3 ss and there is insufficient time for the
NRS to be recognized as a competing 5 ss: the natural sites
are paired and splicing is normal. Future experiments will
determine if similar phenomena occur in the viral context.
Materials and methods
Plasmid constructs
Plasmid pMyc23yw was generated from pMyc23 (Mc-
Nally et al., 1991) by sequentially deleting three restriction
sites, BstXI (the downstream of two sites), KpnI, and XbaI
by restriction site digestion, blunt-ending, and recirculariza-
tion. pMyc(B, H, or A)NRS plasmids were generated by
inserting the wild-type NRS (MroI-SphI fragment contain-
ing KpnI and XbaI sites at the ends) into the BstXI (B),
HindIII (H), and AflII (A) sites within the intron of
pMyc23yw by blunt-end ligation. pMyc23(S)NRS was gen-
erated by replacing the BstXI-HindIII restriction fragment
of pMyc23yw with the same restriction fragment from pRS-
VNeo-in that harbors the NRS at the SacII (S) site (McNally
and McNally, 1999). Plasmids pMyc23(B/S/H/A) mU1
were generated by replacing the wild-type NRS with the
mU1 mutant NRS fragment. This fragment contains muta-
tions in the U1 snRNP binding site and substantially re-
duces NRS activity (McNally and McNally, 1999). The
intron-deletion constructs pMyc23(A)NRSBH and BK
(also made in pMyc23(A)mU1) were generated from
pMyc23(A)NRS by deletion of the upstream intron
BstXI-HindIII fragment or BstXI-KpnI fragment through
digestion, blunt-ending, and recircularization. Plasmids
pMyc23ywBH and BA were generated similarly from
pMyc23yw. Exon insertion constructs were made by in-
serting 178 or 468 bp PCR products into the PvuII site in
the first exon of pMyc23(B)NRS or mU1 by blunt-end
ligation. The small PCR product was generated from nt
2647–2851 of the myc second exon and the large insert
was from nt 4170 – 4637 of myc exon 3. To make the
two-intron construct (Fig. 5A), pRSVNeo-int (Linial,
1987) was digested with PvuII and the 1796-bp exon-
intron-exon fragment was ligated into the PvuII site in
exon 2 of pMyc23yw and the variants harboring the NRS
or mU1 in the BstXI or HindIII sites. The two introns and
30 nts of flanking myc exon are exactly the same. The
first exon is 866 nt, the second exon is 495 nts, and the
third exon is 1103 nt.
Transfection of 293 cells and RNase protection assays
293 cells were grown in minimal essential medium
(GIBCO-BRL) supplemented with 10% fetal calf serum and
penicillin-streptomycin. Cells grown to about 40 to 60%
confluence in 6-cm dishes were transfected with 2 g of
DNA by the calcium phosphate method, and 48 h later total
RNA was isolated with Qiagen RNeasy columns as speci-
636 Y. Wang, M.T. McNally / Virology 313 (2003) 629–637
fied by the manufacturer. RNase protection assays were
carried out as described previously with 5 g of RNA and
a riboprobe that detects unspliced and spliced RNA derived
from pMyc23yw vectors (McNally et al., 1991) or from the
Neo-myc chimeric splice site (McNally and McNally,
1998). Quantitation was done with a Molecular Dynamics
Storm 860 PhosphorImager correcting for uridine content of
the protected unspliced (299 nt) and spliced (137 nt) bands.
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